Smith & Nephew (SN.) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 Aug 2000 07:00 AM
RNS
Interim Results
02 Aug 2000 11:10 AM
RNS
Result of EGM, etc.
27 Jul 2000 05:09 PM
RNS
Holding in Company
19 Jul 2000 11:44 AM
RNS
Advance Notice of Results
11 Jul 2000 12:30 PM
RNS
Launch of New E-Service
05 Jul 2000 06:18 PM
RNS
Special Dividend
30 Jun 2000 04:47 PM
RNS
Directors' Notification of Dealing in Shares
28 Jun 2000 03:00 PM
RNS
Business Reshaping
27 Jun 2000 02:00 PM
RNS
Interim Pre-Close Statement
19 Jun 2000 02:00 PM
RNS
e-Commerce Services
08 Jun 2000 11:19 AM
RNS
Directors' Notification of Dealing in Shares
11 Apr 2000 11:00 AM
RNS
Chairman's Statement
23 Mar 2000 03:52 PM
RNS
Talks with Beiersdorf
23 Feb 2000 02:00 PM
RNS
FDA Approves Marketing of Exogen Ultrasound Device
23 Feb 2000 09:00 AM
RNS
Final Dividend Notification
23 Feb 2000 07:02 AM
RNS
Final Results - Year Ended 31 December 1999
08 Feb 2000 04:27 PM
RNS
Notice of Results
01 Feb 2000 07:28 AM
RNS
Collagenase Wound Care Product Acquired
21 Dec 1999 01:35 PM
RNS
Dermagraft US Clinical Trial Update
21 Dec 1999 01:24 PM
RNS
1999 Preliminary Pre-close Statement
09 Dec 1999 04:57 PM
RNS
Directors' Dealings
16 Nov 1999 04:57 PM
RNS
Directors' Dealings
16 Nov 1999 02:56 PM
RNS
New York Stock Exchange Listing
10 Nov 1999 07:01 AM
RNS
John Robinson to be Succeeded by Dudley Eustace
05 Nov 1999 04:30 PM
RNS
Directors' Dealings
08 Oct 1999 07:00 AM
RNS
Listing on NYSE-Amendment
07 Oct 1999 09:44 AM
RNS
Listing on New York S.E.
21 Sep 1999 03:15 PM
RNS
Strategy Presentation
01 Sep 1999 01:00 PM
RNS
Further re Tender Offer, etc
27 Aug 1999 02:54 PM
RNS
Subsids Tender Offer Extended
26 Jul 1999 08:01 AM
RNS
Acquisition

Smith & Nephew is a British medical technology company that develops, manufactures, and sells medical devices. Products include arthroscopy, trauma, clinical therapy, and orthopaedic reconstruction products. Smith & Nephew's products are sold in over 100 countries, including Europe, the Americas, Asia Pacific, the Middle East, and Africa.

Smith & Nephew operates in three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management.

Smith & Nephew's shares are traded in London and New York, and the company is a constituent of the UK's FTSE100.

Smith and Nephew share price launched at 182p in 1988.

UK 100

Latest directors dealings